Restarting Elective Bariatric and Metabolic Surgery Under a Security Protocol During the COVID-19 Pandemic-a Prospective Observational Cohort Study.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
07 2021
Historique:
received: 15 01 2021
accepted: 22 03 2021
revised: 14 03 2021
pubmed: 13 4 2021
medline: 8 6 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

During the SARS-CoV-2 pandemic, in order to protect the patient and to save hospital beds, cancelation of elective surgeries has become a great challenge. Considering that obesity is a chronic disease and the possible effect imposed by quarantine on weight gain with worsening rates of obesity and metabolic comorbidities, the creation of a protocol for a safe return to bariatric surgery became essential. The aim of this study was to identify the incidence of new-onset severe acute respiratory syndrome coronavirus (SARS-CoV-2) symptoms in patients who underwent bariatric procedures during the declining curve period. Private practice METHODS: A prospective observational cohort study was conducted and included patients with indications for bariatric surgery during the decreasing curve period of the SARS-CoV-2 pandemic who underwent surgery under a hospital security protocol. Patients were asked to answer a questionnaire and had a swab PCR test for SARS-CoV-2 detection. The primary outcome measure was the presence of 14-day and 30-day postoperative symptoms associated with COVID-19. Mortality was also analyzed. Three hundred patients with negative RT-PCR were operated on from May to June 2020. Seventeen patients had their surgery postponed because of a positive RT-PCR test or close contact. None of the patients developed new-onset SARS-CoV-2 symptomatic infection after 30 days of observation. No deaths were reported. Eleven had complications not related to SARS-CoV-2. Even though this population may have a poorer outcome when infected with SARS-CoV-2, this security protocol has shown that the procedure can be safely performed during the outbreak.

Sections du résumé

BACKGROUND
During the SARS-CoV-2 pandemic, in order to protect the patient and to save hospital beds, cancelation of elective surgeries has become a great challenge. Considering that obesity is a chronic disease and the possible effect imposed by quarantine on weight gain with worsening rates of obesity and metabolic comorbidities, the creation of a protocol for a safe return to bariatric surgery became essential.
OBJECTIVE
The aim of this study was to identify the incidence of new-onset severe acute respiratory syndrome coronavirus (SARS-CoV-2) symptoms in patients who underwent bariatric procedures during the declining curve period.
SETTING
Private practice METHODS: A prospective observational cohort study was conducted and included patients with indications for bariatric surgery during the decreasing curve period of the SARS-CoV-2 pandemic who underwent surgery under a hospital security protocol. Patients were asked to answer a questionnaire and had a swab PCR test for SARS-CoV-2 detection. The primary outcome measure was the presence of 14-day and 30-day postoperative symptoms associated with COVID-19. Mortality was also analyzed.
RESULTS
Three hundred patients with negative RT-PCR were operated on from May to June 2020. Seventeen patients had their surgery postponed because of a positive RT-PCR test or close contact. None of the patients developed new-onset SARS-CoV-2 symptomatic infection after 30 days of observation. No deaths were reported. Eleven had complications not related to SARS-CoV-2.
CONCLUSIONS
Even though this population may have a poorer outcome when infected with SARS-CoV-2, this security protocol has shown that the procedure can be safely performed during the outbreak.

Identifiants

pubmed: 33844175
doi: 10.1007/s11695-021-05368-z
pii: 10.1007/s11695-021-05368-z
pmc: PMC8039500
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3083-3089

Références

Lancet Diabetes Endocrinol. 2021 Jan;9(1):7-9
pubmed: 33253631
N Engl J Med. 2020 Oct 15;383(16):1535-1543
pubmed: 33053284
J Leukoc Biol. 2018 Sep;104(3):525-534
pubmed: 30066958
Br J Surg. 2020 Aug;107(9):1097-1103
pubmed: 32293715
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Lancet Diabetes Endocrinol. 2020 Jul;8(7):640-648
pubmed: 32386567
Surg Obes Relat Dis. 2021 Jan;17(1):208-214
pubmed: 33243670
Obes Surg. 2020 Nov;30(11):4623-4626
pubmed: 32506347
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
Obes Surg. 2016 Jul;26(7):1650-3
pubmed: 27107892
JAMA Surg. 2020 Aug 1;155(8):691-702
pubmed: 32530453
Surgery. 2020 Oct;168(4):572-577
pubmed: 32739140
J Surg Oncol. 2020 Dec;122(7):1293-1295
pubmed: 32786076
Surg Obes Relat Dis. 2020 Aug;16(8):981-982
pubmed: 32565394
Obes Surg. 2020 Jun;30(6):2071-2073
pubmed: 32291701
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377
pubmed: 32588943
Nat Rev Endocrinol. 2020 Jul;16(7):341-342
pubmed: 32327737
Br J Surg. 2020 Jun;107(7):785-787
pubmed: 32191340
Surg Obes Relat Dis. 2016 Jan;12(1):165-70
pubmed: 26183302

Auteurs

Marcio P M Balieiro (MPM)

Surgery Service- Hospital Federal de Bonsucesso, Rio de Janeiro, Brazil. marciobalieiro@hotmail.com.
Faculdade de Medicina, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. marciobalieiro@hotmail.com.
Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil. marciobalieiro@hotmail.com.

Michel M da Silva (MM)

Private Practice, Rio de Janeiro, Brazil.

Antônio C J Coelho (ACJ)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Fernando de Barros (F)

Surgery Service- Universidade Federal Fluminense, Rio de Janeiro, Brazil.
Surgery Service- Centro Metabólico da Gávea, Rede Ímpar, Rio de Janeiro, Brazil.

Carlos Saboya (C)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.
Surgery Service- Hospital de Ipanema, Rio de Janeiro, Brazil.

Leonardo R Ferraz (LR)

Surgery Service- Hospital Federal de Bonsucesso, Rio de Janeiro, Brazil.
Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.
Surgery Service- Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.

Mauricio E G Vieira (MEG)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Dyego Sá Benevenuto (DS)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Luiz G de Oliveira E Silva (LG)

Surgery Service- Universidade Federal Fluminense, Rio de Janeiro, Brazil.

Marcio Lucas (M)

Private Practice, Rio de Janeiro, Brazil.

Fernando Valente (F)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Fabio Viegas (F)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Fernando J Kaddoum (FJ)

Surgery Service- Rede D'or/São Luis- Rio de Janeiro, Rio de Janeiro, Brazil.

Luciana J El-Kadre (LJ)

Surgery Service- Centro Metabólico da Gávea, Rede Ímpar, Rio de Janeiro, Brazil.

Fernanda Vaisman (F)

Faculdade de Medicina, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Endocrinology Service, Instituto Nacional do Cancer, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH